Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | News
Search Refinements

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
16-30 of 4385 results
FDA accepts Advaxis' IND for personalized neoepitope immunotherapy ADXS-NEO
The US Food and Drug Administration (FDA) has accepted Advaxis’ Investigational New Drug (IND) application for ADXS-NEO, a personalized neoantigen-targeted approach to cancer immunotherapy that is being developed in partnership with Amgen.
Drug Research > Drug Discovery & Development > News
AstraZeneca’s MedImmune, Sanofi partner to develop infant respiratory drug
By PBR Staff Writer
AstraZeneca’s biologics research and development arm MedImmune and Sanofi Pasteur have agreed to a potential €615m collaboration to develop a monoclonal antibody (mAb) treatment for respiratory syncytial virus (RSV).
Drug Research > Drug Discovery & Development > News
Abzena, UCL secure £3.5m grant from MRC for autoimmune therapy research
A research group from University College London's (UCL) Centre for Rheumatology has been awarded a £3.5m grant from the Medical Research Council (MRC) to advance the development of a novel treatment for anti-phospholipid syndrome (APS) based on Abzena's conjugation technology.
Drug Research > Drug Discovery & Development > News
Astellas, Affinivax to develop MAPS vaccine targeting pneumococcal disease
Affinivax and Astellas Pharma have signed an exclusive worldwide license agreement to develop and market a vaccine targeting Streptococcus pneumoniae (pneumococcus).
Drug Research > Drug Discovery & Development > News
WHO reaffirms critical need for R&D for drug-resistant tuberculosis
The World Health Organization (WHO) has stressed the urgent requirement for research and development (R&D) of new antibiotics to handle the threat posed by drug-resistant tuberculosis (TB).
Drug Research > Drug Discovery & Development > News
Pharma Two B raises $30m for trial of Parkinson's treatment
Pharma Two B, a privately held biopharmaceutical firm engaged in the development of treatments for Parkinson’s disease, has closed $30m financing round.
Drug Research > Drug Discovery & Development > News
Advaxis licenses antigen delivery technology to Sellas for cancer immunotherapy development
Advaxis has licensed its Lm-based antigen delivery technology to Sellas, under a cancer immunotherapy collaboration that could generate up to $358m for Advaxis.
Drug Research > Drug Discovery & Development > News
Incyte partners with University of Pennsylvania on cancer immunotherapy research
Incyte has entered into multi-year research collaboration with the Abramson Cancer Center at the University of Pennsylvania.
Drug Research > Drug Discovery & Development > News
PMV Pharma raises $74m for cancer drugs targeting p53
PMV Pharmaceuticals, which is engaged in the discovery and development of p53-targeted small molecule drugs for the treatment of cancer, has completed a $74m Series B financing round.
Drug Research > Drug Discovery & Development > News
Modus Therapeutics raises £2.9m to support further development of sevuparin for SCD
Modus Therapeutics has raised SEK32m (£2.9m) from existing investors KDev Investments, Östersjöstiftelsen and Praktikerinvest to support a phase two study of a sickle cell disease (SCD) drug.
Drug Research > Drug Discovery & Development > News
Versant Ventures launches biotechnology firm Jecure Therapeutics
Versant Ventures has launched Jecure Therapeutics, a biotechnology firm focused on the discovery of novel therapeutics to treat non-alcoholic steatohepatitis (NASH) and liver fibrosis.
Drug Research > Drug Discovery & Development > News
X-Chem, Janssen extend inflammatory disease collaboration
X-Chem has expanded its collaboration with Janssen Biotech for the discovery of new drug leads for inflammatory disease treatment.
Drug Research > Drug Discovery & Development > News
Horizon Discovery signs master service deal with top three global pharmaceutical firm
Horizon Discovery Group has signed a Master Services Agreement (MSA) with a top three global pharmaceutical company, extending support for their drug discovery and development efforts to its full suite of services.
Drug Research > Drug Discovery & Development > News
Daiichi Sankyo to close Japanese research subsidiary
Daiichi Sankyo has decided to further reorganize its R&D structure by closing its Japanese research subsidiary, Asubio Pharma in Kobe by the end of March 2018 after reviewing its global R&D structure to increase R&D productivity.
Drug Research > Drug Discovery & Development > News
FDA plans to not to hold advisory committee meeting for Portola’s betrixaban NDA
The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) is not planning to hold an Advisory Committee meeting for Portola Pharmaceuticals' New Drug Application (NDA) for betrixaban.
Drug Research > Drug Discovery & Development > News
16-30 of 4385 results